Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine

Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia

Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., & Arnheim, N. (1985) · Science · doi:10.1126/science.2999980 · Cited by 8,956

Cellular uptake of the tat protein from human immunodeficiency virus

Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,783

Importance of the nef gene for maintenance of high virus loads and for development of AIDS

Kestier, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D., & Desrosiers, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90097-i · Cited by 1,596

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., et al. (1998) · Science · doi:10.1126/science.279.5359.2103 · Cited by 1,383

Tat-mediated delivery of heterologous proteins into cells.

Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., & Barsoum, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.664 · Cited by 1,225

Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef Gene

Daniel, M. D., Kirchhoff, F., Czajak, S. C., Sehgal, P. K., & Desrosiers, R. C. (1992) · Science · doi:10.1126/science.1470917 · Cited by 1,015

Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120

Westendorp, M. O., Frank, R., Ochsenbauer, C., Stricker, K., Dhein, J., Walczak, H., Debating, K.-M., & Krammer, P. H. (1995) · Nature · doi:10.1038/375497a0 · Cited by 975

Human Retroviruses and Aids - 1999

Kuiken, C., & Foley, B. (1999) · doi:10.2172/1186019 · Cited by 952

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

Ensoli, B., Barillari, G., Salahuddin, S. Z., Gallo, R. C., & Wong-Staal, F. (1990) · Nature · doi:10.1038/345084a0 · Cited by 896

Trans -Activator Gene of Human T-Lymphotropic Virus Type III (HTLV-III)

Arya, S. K., Guo, C., Josephs, S. F., & Wong-Staal, F. (1985) · Science · doi:10.1126/science.2990040 · Cited by 858

Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation

Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V, Gendelman, R., Morgan, R. A., Wingfield, P., & Gallo, R. C. (1993) · Journal of Virology · doi:10.1128/jvi.67.1.277-287.1993 · Cited by 796

The trans-activator gene of HTLV-III is essential for virus replication

Fisher, A. G., Feinberg, M. B., Josephs, S. F., Harper, M. E., Marselle, L. M., Reyes, G., Gonda, M. A., Aldovini, A., Debouk, C., Gallo, R. C., et al. (1986) · Nature · doi:10.1038/320367a0 · Cited by 628

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160

Berman, P. W., Gregory, T. J., Riddle, L., Nakamura, G. R., Champe, M. A., Porter, J. P., Wurm, F. M., Hershberg, R. D., Cobb, E. K., & Eichberg, J. W. (1990) · Nature · doi:10.1038/345622a0 · Cited by 590

Induction of Apoptosis in Uninfected Lymphocytes by HIV-1 Tat Protein

Li, C. J., Friedman, D. J., Wang, C., Metelev, V., & Pardee, A. B. (1995) · Science · doi:10.1126/science.7716549 · Cited by 580

Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

Ensoli, B., Gendelman, R., Markham, P., Fiorelli, V., Colombini, S., Raffeld, M., Cafaro, A., Chang, H.-K., Brady, J. N., & Gallo, R. C. (1994) · Nature · doi:10.1038/371674a0 · Cited by 570

Pathogenicity of Live, Attenuated SIV After Mucosal Infection of Neonatal Macaques

Baba, T. W., Jeong, Y. S., Pennick, D., Bronson, R., Greene, M. F., & Ruprecht, R. M. (1995) · Science · doi:10.1126/science.7892606 · Cited by 489

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region

Chang, H. C., Samaniego, F., Nair, B. C., Buonaguro, L., & Ensoli, B. (1997) · AIDS · doi:10.1097/00002030-199712000-00006 · Cited by 442

A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact

Perez, C., Albert, I., DeFay, K., Zachariades, N., Gooding, L., & Kriegler, M. (1990) · Cell · doi:10.1016/0092-8674(90)90158-b · Cited by 403

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

Calarota, S., Bratt, G., Nordlund, S., Hinkula, J., Leandersson, A.-C., Sandström, E., & Wahren, B. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09440-3 · Cited by 400

The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.

Barillari, G., Gendelman, R., Gallo, R. C., & Ensoli, B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7941 · Cited by 356

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.

Girard, M., Kieny, M. P., Pinter, A., Barre-Sinoussi, F., Nara, P., Kolbe, H., Kusumi, K., Chaput, A., Reinhart, T., & Muchmore, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.542 · Cited by 352

Inhibition of Antigen-Induced Lymphocyte Proliferation by Tat Protein from HIV-1

Viscidi, R. P., Mayur, K., Lederman, H. M., & Frankel, A. D. (1989) · Science · doi:10.1126/science.2556795 · Cited by 329

Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL

Ando, K., Hiroishi, K., Kaneko, T., Moriyama, T., Muto, Y., Kayagaki, N., Yagita, H., Okumura, K., & Imawari, M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5283 · Cited by 249

Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi’s sarcoma pathogenesis

Barillari, G., Buonaguro, L., Fiorelli, V, Hoffman, J., Michaels, F., Gallo, R. C., & Ensoli, B. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.11.3727 · Cited by 193

Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence

Whatmore, A. M., Cook, N., Hall, G. A., Sharpe, S., Rud, E. W., & Cranage, M. P. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.5117-5123.1995 · Cited by 180

Interferon α and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS

Zagury, D., Lachgar, A., Chams, V., Fall, L. S., Bernard, J., Zagury, J.-F., Bizzini, B., Gringeri, A., Santagostino, E., Rappaport, J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3851 · Cited by 172

Tat Protein Induces Human Immunodeficiency Virus Type 1 (HIV-1) Coreceptors and Promotes Infection with both Macrophage-Tropic and T-Lymphotropic HIV-1 Strains

Huang, L., Bosch, I., Hofmann, W., Sodroski, J., & Pardee, A. B. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8952-8960.1998 · Cited by 172

Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens

Jassoy, C., Harrer, T., Rosenthal, T., NAVIA, B. A., Worth, J. L., Johnson, R. P., & Walker, B. D. (1993) · Journal of Virology · doi:10.1128/jvi.67.5.2844-2852.1993 · Cited by 127

Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness

Subramanyam, M., Gutheil, W. G., Bachovchin, W. W., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.6.2544 · Cited by 118

Effect of Antibody to HIV-1 Tat Protein on Viral Replication in Vitro and Progression of HIV-1 Disease in Vivo

Re, M. C., Furlini, G., Vignoli, M., et al. (1995) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199512000-00003 · Cited by 114

Role of TNF-alpha in CD8+ cytotoxic T lymphocyte-mediated lysis

Ratner, A., & Clark, W. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.10.4303 · Cited by 106

Regulation of Cellular Gene Expression and Function by the Human Immunodeficiency Virus Type 1 Tat Protein

Chang, H.-K., Gallo, R. C., & Ensoli, B. (1995) · Journal of Biomedical Science · doi:10.1159/000456857 · Cited by 94

Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV‐1

REISS, P. C., Lange, J. M. A., de Ronde, A., et al. (1990) · Journal of Medical Virology · doi:10.1002/jmv.1890300303 · Cited by 78

Anti-HIV Type 1 Cytotoxic T Lymphocyte Effector Activity and Disease Progression in the First 8 Years of HIV Type 1 Infection of Homosexual Men

Rinaldo, C. R., Beltz, L. A., Huang, X., Gupta, P., FAN, Z., & Torpey, D. J. (1995) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1995.11.481 · Cited by 64

Heteroduplex mobility assay and phylogenetic analysis of V3 region sequences of human immunodeficiency virus type 1 isolates from Gulu, northern Uganda. The Italian-Ugandan Cooperation AIDS Program

Buonaguro, L., Guadio, E. D., Monaco, M., Greco, D., Corti, P., Beth‐Giraldo, E., Buonaguro, L., & Giraldo, G. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.7971-7981.1995 · Cited by 56

Epitopes for natural antibodies of human immunodeficiency virus (HIV)-negative (normal) and HIV-positive sera are coincident with two key functional sequences of HIV Tat protein.

Rodman, T. C., To, S. E., Hashish, H., & Manchester, K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7719 · Cited by 47

Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys.

Titti, F., Fabio, S. D., Amadori, A., Monardo, F., Verani, P., Maggiorella, M. T., Sernicola, L., Panzini, G., Koanga-Mogtomo, M. L., Zamarchi, R., et al. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-10-2529 · Cited by 43

A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogen

Davis, D. A., Morein, B., Åkerblom, L., Lövgren‐Bengtsson, K., van Gils, M. E., Bogers, W. M. J. M., Teeuwsen, V. J. P., & Heeney, J. L. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00084-4 · Cited by 23

Simultaneous measurement of NK cell cytotoxicity against two target cell lines labelled with fluorescent lanthanide chelates

Lövgren, J., & Blomberg, K. R. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90289-5 · Cited by 17

Nanoparticles in modern medicine: state of the art and future challenges.

(2007) · PubMed Central · Cited by 484

Selective CXCR4 antagonism by Tat: Implications for in vivo expansion of coreceptor use by HIV-1

Xiao, H., Neuveut, C., Tiffany, H. L., Benkirane, M., Rich, E. A., Murphy, P. M., & Jeang, K.-T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11466 · Cited by 368